Fetal microchimeric cells in a fetus-treats-its-mother paradigm do not contribute to dystrophin production in serially parous mdx females

Stem Cells and Development

Volumn 21, Issue 15, 2012, Pages 2809-2816

  Seppanen, Elke Jane ^a   Hodgson, Samantha Susan ^a   Khosrotehrani, Kiarash ^a   Bou Gharios, George ^a,b   Fisk, Nicholas M ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; NOTEXIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FETAL STEM CELL; FETUS; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MICROCHIMERISM; MOUSE; MUSCLE NECROSIS; MUSCLE REGENERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PUERPERIUM; TIBIALIS ANTERIOR MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; DYSTROPHIN; ELAPID VENOMS; FEMALE; FETAL STEM CELLS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PREGNANCY; REGENERATION;

ANIMALIA; MUS;

EID: 84870426579     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0047     Document Type: Article

References (45)

1. Bianchi DW, GK Zickwolf, GJ Weil, S Sylvester and MA DeMaria. (1996). Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93:705-708.
2. Khosrotehrani K, KL Johnson, DH Cha, RN Salomon and DW Bianchi. (2004). Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 292:75-80.
3. Khosrotehrani K, M Leduc, V Bachy, S Nguyen Huu, M Oster, A Abbas, S Uzan and S Aractingi. (2008). Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol 180:889-897.
4. Nassar D, C Droitcourt, E Mathieu-d'Argent, MJ Kim, K Khosrotehrani and S Aractingi. (2012). Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing. FASEB J 26:149-157.
5. Nelson JL. (1998). Microchimerism and the causation of scleroderma. Scand J Rheumatol Suppl 107:10-13.
6. Nguyen Huu S, M Oster, MF Avril, F Boitier, L Mortier, MA Richard, D Kerob, E Maubec, P Souteyrand, et al. (2009). Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol 174:630-637.
7. O'Donoghue K, HA Sultan, FA Ai-Allaf, JR Anderson, J Wyatt-Ashmead and NM Fisk. (2008). Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod Biomed Online 16:382-390.
8. Sunami R, M Komuro, T Yuminamochi, K Hoshi and S Hirata. (2010). Fetal cell microchimerism develops through the migration of fetus-derived cells to the maternal organs early after implantation. J Reprod Immunol 84:117-123.
9. Mikhail MA, H M'Hamdi, J Welsh, N Levicar, SB Marley, JP Nicholls, NA Habib, LS Louis, NM Fisk and MY Gordon. (2008). High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum Reprod 23: 928-933.
10. Thomas MR, R Williamson, I Craft and CH Rodeck. (1994). The time of appearance, and quantitation, of fetal DNA in the maternal circulation. Ann N Y Acad Sci 731:217-225.
11. Nguyen Huu S, M Oster, S Uzan, F Chareyre, S Aractingi and K Khosrotehrani. (2007). Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci USA 104:1871-1876.
12. O'Donoghue K, J Chan, J de la Fuente, N Kennea, A Sandison, JR Anderson, IA Roberts and NM Fisk. (2004). Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 364:179-182.
13. Zeng XX, KH Tan, A Yeo, P Sasajala, X Tan, ZC Xiao, G Dawe and G Udolph. (2010). Pregnancy-associated progenitor cells differentiate and mature into neurons in the maternal brain. Stem Cells Dev 19:1819-1830.
14. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654.
15. Zhang ZY, SH Teoh, MS Chong, JT Schantz, NM Fisk, MA Choolani and J Chan. (2009). Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27:126-137.
16. Winder SJ. (1997). The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J Muscle Res Cell Motil 18:617-629.
17. Chan J, SN Waddington, K O'Donoghue, H Kurata, PV Guillot, C Gotherstrom, M Themis, JE Morgan and NM Fisk. (2007). Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells 25:875-884.
18. Ferrari G, G Cusella-De Angelis, M Coletta, E Paolucci, A Stornaiuolo, G Cossu and F Mavilio. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
19. Sohn RL and E Gussoni. (2004). Stem cell therapy for muscular dystrophy. Expert Opin Biol Ther 4:1-9.
20. Tedesco FS, A Dellavalle, J Diaz-Manera, G Messina and G Cossu. (2010). Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 120:11-19.
21. Zammit PS, TA Partridge and Z Yablonka-Reuveni. (2006). The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 54:1177-1191.
22. Gussoni E, RR Bennett, KR Muskiewicz, T Meyerrose, JA Nolta, I Gilgoff, J Stein, YM Chan, HG Lidov, et al. (2002). Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 110:807-814.
23. Zammit PS, JJ Carvajal, JP Golding, JE Morgan, D Summerbell, J Zolnerciks, TA Partridge, PW Rigby and JR Beauchamp. (2004). Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements. Developmental biology 273:454-465.
24. Plant DR, FE Colarossi and GS Lynch. (2006). Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine. Muscle Nerve 34:577-585.
25. Lefaucheur JP and A Sebille. (1995). The cellular events of injured muscle regeneration depend on the nature of the injury. Neuromusc Disord 5:501-509.
26. Vater R, MJ Cullen, LV Nicholson and JB Harris. (1992). The fate of dystrophin during the degeneration and regeneration of the soleus muscle of the rat. Acta Neuropathol 83:140-148.
27. Pan D, R Gunther, W Duan, S Wendell, W Kaemmerer, T Kafri, IM Verma and CB Whitley. (2002). Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol Ther 6:19-29.
28. Jackson KA, DS Snyder and MA Goodell. (2004). Skeletal muscle fiber-specific green autofluorescence: potential for stem cell engraftment artifacts. Stem Cells 22:180-187.
29. Khosrotehrani K, KL Johnson, S Guegan, H Stroh and DW Bianchi. (2005). Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol 66:1-12.
30. Lu QL, GE Morris, SD Wilton, T Ly, OV Artem'yeva, P Strong and TA Partridge. (2000). Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol 148:985-996.
31. Wernig G, V Janzen, R Schafer, M Zweyer, U Knauf, O Hoegemeier, RR Mundegar, S Garbe, S Stier, et al. (2005). The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment. Proc Natl Acad Sci USA 102:11852-11857.
32. Yokota T, QL Lu, JE Morgan, KE Davies, R Fisher, S Takeda and TA Partridge. (2006). Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci 119:2679-2687.
33. Boldrin L, PS Zammit, F Muntoni and JE Morgan. (2009). Mature adult dystrophic mouse muscle environment does not impede efficient engrafted satellite cell regeneration and self-renewal. Stem Cells 27:2478-2487.
34. Fujiki Y, KL Johnson, H Tighiouart, I Peter and DW Bianchi. (2008). Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod 79:841-848.
35. Kara RJ, P Bolli, IKarakikes, IMatsunaga, J Tripodi,OTanweer, P Altman, NS Shachter, A Nakano, V Najfeld and HW Chaudhry. (2012). Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res 110:82-93.
36. Coulton GR, JE Morgan, TA Partridge and JC Sloper. (1988). The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14:53-70.
37. Heslop L, JE Morgan and TA Partridge. (2000). Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113 (Pt 12):2299-2308.
38. Corbel SY, A Lee, L Yi, J Duenas, TR Brazelton, HM Blau and FM Rossi. (2003). Contribution of hematopoietic stem cells to skeletal muscle. Nat Med 9:1528-1532.
39. Morrison J, DB Palmer, S Cobbold, T Partridge and G Bou-Gharios. (2005). Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse. Am J Pathol 166: 1701-1710.
40. Tinsley J, N Deconinck, R Fisher, D Kahn, S Phelps, JM Gillis and K Davies. (1998). Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4:1441-1444.
41. Wakefield PM, JM Tinsley, MJ Wood, R Gilbert, G Karpati and KE Davies. (2000). Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther 7:201-204.
42. Chandrasekharan K, JH Yoon, Y Xu, S deVries, M Camboni, PM Janssen, A Varki and PT Martin. (2010). A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med 2:42ra54.
43. Sicinski P, Y Geng, AS Ryder-Cook, EA Barnard, MG Darlison and PJ Barnard. (1989). The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244:1578-1580.
44. Fujiki Y, KL Johnson, I Peter, H Tighiouart and DW Bianchi. (2009). Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers. Biol Reprod 81:26-32.
45. Sanes JR. (2003). The basement membrane/basal lamina of skeletal muscle. The J Biol Chem 278:12601-12604.